Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Richard Adcock currently holds 152,439 shares of ImmunityBio, Inc. (IBRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Richard Adcock has been a net buyer of IBRX stock. They have purchased $17.0K and sold $0 worth of shares.
Richard Adcock's most recent insider trade was on Feb 22, 2026, when they sold 152,439 shares at $0.00 per share.
Richard Adcock serves as Executive at ImmunityBio, Inc. (IBRX). They have executed 26 insider transactions totaling $17.0K over their tenure at the company.
Richard Adcock holds the position of Executive at ImmunityBio, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
Richard Adcock has shown a buying trading pattern, with $17.0K in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Richard Adcock was on Feb 5, 2021, when they sold $1.6M worth of NK shares. This transaction involved 68,171 shares at $23.72 per share.
Richard Adcock currently owns 152,439 shares of ImmunityBio, Inc. (IBRX), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Richard Adcock's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Richard Adcock has 26 Form 4 filings on record as an insider at ImmunityBio, Inc..
Set alerts for Richard Adcock and 40,000+ other insiders.